Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients

Ítems similars

• Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007–2014
  per: Fan, Wenjun, et al.
  Publicat: (2020)
• Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007–2014
  per: Fan, Wenjun, et al.
  Publicat: (2019)
• Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
  per: Budoff, Matthew, et al.
  Publicat: (2018)
• High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
  per: Toth, Peter P., et al.
  Publicat: (2018)
• Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
  per: Brinton, Eliot A, et al.
  Publicat: (2013)